NO993881D0 - Mikrogranulater inneholdende cisplatin - Google Patents

Mikrogranulater inneholdende cisplatin

Info

Publication number
NO993881D0
NO993881D0 NO993881A NO993881A NO993881D0 NO 993881 D0 NO993881 D0 NO 993881D0 NO 993881 A NO993881 A NO 993881A NO 993881 A NO993881 A NO 993881A NO 993881 D0 NO993881 D0 NO 993881D0
Authority
NO
Norway
Prior art keywords
containing cisplatin
microgranules containing
microgranules
cisplatin
Prior art date
Application number
NO993881A
Other languages
English (en)
Other versions
NO993881L (no
NO323230B1 (no
Inventor
Patrice Debregeas
Gerard Leduc
Pascal Oury
Pascal Suplie
Original Assignee
Ethypharm Lab Prod Ethiques
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Lab Prod Ethiques filed Critical Ethypharm Lab Prod Ethiques
Publication of NO993881D0 publication Critical patent/NO993881D0/no
Publication of NO993881L publication Critical patent/NO993881L/no
Publication of NO323230B1 publication Critical patent/NO323230B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/243Platinum; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO19993881A 1997-02-11 1999-08-11 Mikrogranulater for kontrollert frigjoring for oral administrering som inneholder cisplatin, farmasoytiske preparater derav og anvendelse derav. NO323230B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9701545A FR2759293B1 (fr) 1997-02-11 1997-02-11 Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
PCT/FR1998/000251 WO1998034599A1 (fr) 1997-02-11 1998-02-10 Microgranules contenant du cisplatine

Publications (3)

Publication Number Publication Date
NO993881D0 true NO993881D0 (no) 1999-08-11
NO993881L NO993881L (no) 1999-09-29
NO323230B1 NO323230B1 (no) 2007-02-05

Family

ID=9503556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19993881A NO323230B1 (no) 1997-02-11 1999-08-11 Mikrogranulater for kontrollert frigjoring for oral administrering som inneholder cisplatin, farmasoytiske preparater derav og anvendelse derav.

Country Status (24)

Country Link
US (2) US6458389B1 (no)
EP (1) EP0971702B1 (no)
JP (1) JP4549445B2 (no)
KR (1) KR100471672B1 (no)
AR (1) AR011133A1 (no)
AT (1) ATE255409T1 (no)
BG (1) BG64247B1 (no)
BR (1) BR9807319A (no)
CA (1) CA2282082C (no)
DE (1) DE69820239T2 (no)
DK (1) DK0971702T3 (no)
EA (1) EA001760B1 (no)
ES (1) ES2210726T3 (no)
FR (1) FR2759293B1 (no)
HU (1) HU225425B1 (no)
IL (1) IL131326A (no)
IN (1) IN187998B (no)
NO (1) NO323230B1 (no)
NZ (1) NZ337216A (no)
PL (1) PL191631B1 (no)
PT (1) PT971702E (no)
TW (1) TW561055B (no)
WO (1) WO1998034599A1 (no)
ZA (1) ZA981123B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050096304A1 (en) * 1998-09-08 2005-05-05 David White Method of treating cancer using dithiocarbamate derivatives
FR2790668B1 (fr) * 1999-03-12 2002-07-26 D B F Granules contenant une substance vegetale et leur procede de preparation
CN1164262C (zh) * 1999-05-17 2004-09-01 D.B.F.公司 含有植物物质的颗粒及其制备方法
CA2541578C (en) * 2003-10-10 2014-03-25 Ethypharm Sustained-release microgranules containing gingko biloba extract and the process for manufacturing these
FR2861990B1 (fr) * 2003-11-10 2006-02-10 Nouveaux Produits Pharma Comprimes faiblement doses a reseau de polymeres
EP1958625A1 (en) * 2004-11-18 2008-08-20 Brystol-Myers Squibb Company Enteric coate bead comprising ixabepilone and preparation thereof
KR20070092972A (ko) * 2004-12-10 2007-09-14 테무릭크 가부시키가이샤 전이암 치료제 및 암 전이 억제제
US9107824B2 (en) 2005-11-08 2015-08-18 Insmed Incorporated Methods of treating cancer with high potency lipid-based platinum compound formulations administered intraperitoneally
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
MX2010003036A (es) * 2007-09-21 2010-04-09 Evonik R Hm Gmbh Composicion farmaceutica de liberacion controlada ph dependiente para no opioides con resistencia a la influencia del etanol.
CN101801357B (zh) * 2007-09-21 2013-08-07 赢创罗姆有限公司 耐受乙醇的影响的pH依赖性受控释放的药物组合物
US20110070302A2 (en) * 2008-01-10 2011-03-24 Evonik Roehm Gmbh Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
EP2230932B1 (en) * 2008-01-10 2017-03-29 Evonik Röhm GmbH Coated pharmaceutical or nutraceutical preparation with enhanced active substance release in the colon
DK177529B1 (en) * 2009-10-23 2013-09-08 Bio Bedst Aps Liposomes with improved storage stability
CA2688202C (en) * 2009-12-11 2012-11-13 Bj Services Company Viscoelastic fluids containing hydroxyethyl cellulose
EP2371356B1 (en) * 2010-03-12 2012-12-19 Phoeme GmbH Multi-particle pharmaceutical formulation for colon absorption
US8070047B1 (en) * 2010-12-02 2011-12-06 Rohm And Haas Electronic Materials Llc Flux composition and method of soldering
CN115414384A (zh) 2012-09-04 2022-12-02 埃莱森制药有限责任公司 用顺铂脂质复合物预防癌症的肺部复发
JP6487534B2 (ja) 2014-09-05 2019-03-20 シンビオミックス セラピューティクス、エルエルシー 細菌性膣炎の治療に使用するためのセクニダゾール
US10238688B2 (en) * 2015-04-24 2019-03-26 Genedia Biotech Co., Ltd. Combination therapies for bladder cancer
US11253501B2 (en) 2015-06-01 2022-02-22 Lupin Inc. Secnidazole formulations and use in treating bacterial vaginosis
DK3307239T3 (da) 2015-06-12 2020-11-23 Vaxart Inc Formuleringer til indgivelse af RSV- og norovirusantigener i tyndtarmen
TWI795462B (zh) 2017-11-17 2023-03-11 日商鹽野義製藥股份有限公司 光安定性及溶出性優異的醫藥製劑
AR115354A1 (es) 2018-04-24 2020-12-23 Shionogi & Co Forma de dosis sólida con excelente estabilidad
MX2020011130A (es) * 2018-04-24 2022-09-09 Shionogi & Co Forma de dosificacion solida que tiene excelente estabilidad.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0059817B1 (fr) * 1981-03-11 1985-10-09 Mirko Beljanski Serpentine; alstonine et sempervirine, médicaments inhibant spécifiquement les cellules cancéreuses et tumorales
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
DE3523454A1 (de) * 1985-07-01 1987-01-08 Eberhard Prof Dr Nuernberg Formkoerper
US4925674A (en) * 1988-08-25 1990-05-15 Himedics, Inc. Amoxicillin microencapsulated granules
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
JPH05294839A (ja) * 1992-04-20 1993-11-09 Biomaterial Universe Kk シスプラチン含有生体内分解吸収性高分子の微小球お よびその製造法
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤
JPH0789849A (ja) * 1993-09-20 1995-04-04 Fujisawa Pharmaceut Co Ltd 徐放性製剤
JPH0859460A (ja) * 1994-08-22 1996-03-05 Tanaka Kikinzoku Kogyo Kk 抗ガン剤内包キトサンミクロスフェア及びその製造法
US5637319A (en) * 1995-03-01 1997-06-10 Takada; Kanji Controlled-release preparations
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin

Also Published As

Publication number Publication date
IL131326A (en) 2005-03-20
DE69820239T2 (de) 2004-10-07
DE69820239D1 (de) 2004-01-15
IN187998B (no) 2002-08-03
ES2210726T3 (es) 2004-07-01
ATE255409T1 (de) 2003-12-15
TW561055B (en) 2003-11-11
FR2759293A1 (fr) 1998-08-14
JP2001512433A (ja) 2001-08-21
PL335107A1 (en) 2000-04-10
JP4549445B2 (ja) 2010-09-22
CA2282082A1 (fr) 1998-08-13
EP0971702B1 (fr) 2003-12-03
PT971702E (pt) 2004-04-30
BR9807319A (pt) 2000-04-18
PL191631B1 (pl) 2006-06-30
CA2282082C (fr) 2005-10-18
AU6626798A (en) 1998-08-26
NZ337216A (en) 2000-09-29
WO1998034599A1 (fr) 1998-08-13
EA001760B1 (ru) 2001-08-27
DK0971702T3 (da) 2004-04-13
KR20000070997A (ko) 2000-11-25
BG64247B1 (bg) 2004-07-30
HUP0001719A3 (en) 2005-11-28
HUP0001719A2 (hu) 2000-11-28
FR2759293B1 (fr) 1999-04-30
AU744001B2 (en) 2002-02-14
ZA981123B (en) 1998-08-20
KR100471672B1 (ko) 2005-03-07
EA199900734A1 (ru) 2000-04-24
EP0971702A1 (fr) 2000-01-19
NO993881L (no) 1999-09-29
US20030017210A1 (en) 2003-01-23
US6458389B1 (en) 2002-10-01
AR011133A1 (es) 2000-08-02
BG103647A (en) 2000-03-31
HU225425B1 (en) 2006-11-28
NO323230B1 (no) 2007-02-05
IL131326A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
DK0971702T3 (da) Mikrogranula indeholdende cisplatin
DE69839157D1 (de) Fullurene enthaltendes katherdersystem
DE69802187D1 (de) Mullit enthaltende schleifgegenstände
PT860428E (pt) Compostos pirimidiona
IS5479A (is) Efnasambönd
IS5478A (is) Efnasambönd
IS5477A (is) Efnasambönd
ID22850A (id) Senyawa-senyawa pirazina
NO994877D0 (no) Kalsilytiske forbindelser
DE69839287D1 (de) Steckverbinder
DE69810285D1 (de) Steckverbinder
ID20323A (id) Senyawa-senyawa triazinilaminostilbena
EE9900448A (et) Ühendid
DE69833786D1 (de) Bolzenartiger verbinder
NO20002159L (no) Piperazin-cyklodekstrin-komplekser
DK0862850T3 (da) Mejetærsker
NO995404D0 (no) Forbindelser
EE9900602A (et) Ühendid
ID22983A (id) Senyawa-senyawa fluorometoksimino
NO995007D0 (no) Forbindelser
DE69737634D1 (de) Insektizide oxadiazinverbindungen
FR2763752B3 (fr) Connecteur
DE69813583T2 (de) Kabelverbinder
KR970060407U (ko) 운반구
KR970049136U (ko) 연결구

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees